BCL2 and cancer: Screening of several key proteins controlling cell cycle, development, metabolism, apoptosis, and growth showed that downregulation of Bmi‐1 reduced p‐AKT, Nestin, Bcl2, and GSK3b protein levels and induced differentiation in cancer cells, as well as decreased proliferation, survival, migration, and clonogenicity [69].